Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Ono Pharmaceutical
Ono Pharmaceutical
Activities:
Research & Development
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Finance
Research funding round-up
Capital to support the development of new drugs and technology around the world
Research & Development
Bristol-Myers Squibb and Ono Pharmaceutical agree immuno-oncology collaboration
Japan, South Korea and Taiwan
Manufacturing
AMRI and Ono extend drug discovery pact
Will collaborate on hit-to-lead and lead optimisation for two new molecules
Research & Development
BioFocus and Ono sign CNS drug discovery agreement
BioFocus will use its drug discovery platform to deliver leads and clinical candidates
Finance
Merck Serono and Ono to co-operate
On multiple sclerosis and cancer therapies
Research & Development
Xention and Ono extend drug discovery agreement
Collaboration to continue for a third year
Regulatory
BioSeek and Ono agree research collaboration
BioSeek will apply its BioMAP technology to Ono drug target
Subscribe now